Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

Introduction While pathogen genomics using next-generation sequencing (NGS) has been recommended by the WHO as an essential ...

Dual-omic analysis to reveal gene regulatory network of immune landscape in childhood solid tumors and implications for immunotherapy. Phase 1/2 study of TSN222, a novel dual action tumor immune ...

Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...

As next-generation sequencing (NGS) applications expand, researchers face growing pressure to generate accurate, uniform data from increasingly complex and low input samples.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...